Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Incyte Who? Why This Biotech Would Give Gilead a Bang for Its Buck January 25, 2017 Sarepta Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD February 9, 2017 Innate Pharma To Hold Its Annual General Meeting Of Shareholders On June 23, 2017 May 22, 2017
